FOURNEL ADVISORY advises ATHENA PHARMACEUTICALS on the acquisition of 100% of MEDIPHA SANTÉ’s shares and the structuring of its financing
Athena develops and manufactures high value-added medicines for both mature and emerging markets. The company offers an integrated platform covering the full value chain—from R&D to commercialization—through its two manufacturing sites in France and India (with a third site planned for 2026) and its R&D centers.
This acquisition enables Athena Pharmaceuticals to strengthen its footprint in France and broaden its offering with complementary expertise, thereby consolidating its position as a leading integrated player in pharmaceutical services at the European level.
Medipha Santé is a well-established pharmaceutical services company in France, specializing in marketing authorization holding, regulatory affairs, and pharmacovigilance